First Turn Management’s Roivant Sciences ROIV Stock Holding History

First Turn Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33M	Buy	1,190,118 +3,301	+0.3%	+$84.8K	3.68%	11
2025 Q4	$25.8M	Buy	1,186,817 +227,114	+24%	+$4.48M	2.94%	17
2025 Q3	$14.5M	Buy	+959,703	New	+$11.9M	2.18%	23
2024 Q1	–	Sell	-1,363,504	Closed	-$15.3M	–	37
2023 Q4	$15.3M	Buy	+1,363,504	New	+$13.3M	2.2%	25

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

First Turn Management's ROIV Position: Q1 2026 in Review

First Turn Management increased its Roivant Sciences (ROIV) stake by 0.28% in Q1 2026, buying an estimated $84.8K and bringing the position to 1,190,118 shares worth $33M. The position accounts for 3.68% of the portfolio, ranked #11.

First Turn Management first reported a position in ROIV in Q4 2023 and has held it in 4 quarters since. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

First Turn Management held 1,190,118 shares of Roivant Sciences worth $33M as of Q1 2026.
First Turn Management bought 3,301 Roivant Sciences shares in Q1 2026, an estimated $84.8K.
Roivant Sciences made up 3.68% of First Turn Management's portfolio in Q1 2026, its #11 holding.
First Turn Management first reported a position in Roivant Sciences in Q4 2023 and has held it in 4 quarters since.
439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on First Turn Management's 13F filing for Q1 2026, filed 15 May 2026.